Vicor Corporation, together with its subsidiaries, designs, develops, manufactures, and markets modular power components and power systems for converting electrical power for use in electrically powered devices in the Un…
FAIL · Does not pass the screen
159.07 USD
Price as of 4 Nov 2026Daily close, not a live quote
Screened 2026-11-04 · the tape above runs as of 20:03 UTC · two dates, stated on purpose · verdict and workings shown in full · never trimmed
Key facts today
Price159.07 USD at the 4 Nov 2026 close
Our value readUndervalued vs our fair value, as of 4 Nov 2026
Positioning no disclosures inside 60 days, left as found
Options put/call open interest 2.69, read 2026-11-03
Ethical does not pass the values gate
Price159.07 USD
Fair value268.91
Ethical score70.0/100
Value readUndervaluedas of 4 Nov 2026
Our investment reviews on this name
2026-10-27Read Distribution194.77-18.3% to today ✓Markup gives way to Distribution after a 27% slide in 4 weeks
2026-10-02Read Markup268.34-40.7% to today Distribution gives way to Markup after a 40% rise in 7 weeks
2026-08-16Read Distribution192.12-17.2% to today ✓Markup gives way to Distribution after a 37% slide in 6 weeks
2026-07-02Read Markup303.77-47.6% to today First review on file: Markup
Our analytic regime reads on this name, dated and marked against the screened price. Small sample per name, and separate from the daily-framework accuracy on the Track Record page.
Vicor Corp holds its Distribution at $159.07. Elevated stress, defensive posture warranted, held for 1 days.
As held on the ledger · 2026-11-04
Phase
Distribution · caution
Quantitative state
Elevated stress, defensive posture warranted, held for 1 days
Price at the screen
$159.07
Valuation
50.85 trailing · 32.09 forward price to earnings
Values screen
FAIL· score 70.0
Beta
2.38
The Workings
Five Screens, Shown in Full
Does not pass. Accounts receivable
Test
Figure
Limit
What it means
Status
Business activity
Permissible
Core business clean
Its core business isn't built on prohibited lines: no gambling, alcohol, tobacco, weapons, or interest-based lending.
Pass
Debt load
0.91%
Below 33%
Interest-bearing debt is just 0.9% of its assets, well under the one-third ceiling: it does not run on borrowed money.
Pass
Interest-bearing cash
0.31%
Below 33%
Cash held in interest-bearing accounts and securities is 0.3% of assets, under the one-third limit.
Pass
Receivables
58.98%
Below 49%
Money owed to the company is 59.0% of assets, above the 49% limit.
Fail
Revenue purity
2.68%
Below 5%
Only 2.7% of revenue comes from non-compliant sources, under the 5% line.
Pass
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
The Ethical Read
Why It Falls Short, in Plain English
Vicor's business is fine, but its receivables are about 59% of its assets, well over the ~49% line, so it does not pass on the financial screens.
Read as at 2026-11-05. It updates when the underlying figures move, and past reads are kept below.
Follow this verdict
Get an email when VICR's ethical verdict changes
Today VICR does not pass the screen. If new figures move it to a pass, we send you one short email with the before and after. Verdicts change rarely, so you may not hear from us for a long time.
Free, no account needed. Every email has a link to stop.
What the Numbers Say It Is Worth
The Fair Value Range
Our analysis reads Undervalued vs our fair value, as of 4 Nov 2026: it trades at roughly a 41% discount to our $268.91 fair value, narrow competitive moat, 78.50% revenue growth.
Fair value range in USD, drawn from the 2026-11-04 screen. The gold marker is the market price at the same screen. A 40.8% discount to the base estimate.
Where our models see it going: fair-value estimate $268.91, with a range of $268.91 to $309.25, dated to the 2026-11-04 screen.
Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.
The Business, in Plain Words
Power modules trade at a steep premium
Every laptop, server rack and electric vehicle draws power that must be converted cleanly and efficiently. Vicor builds the modular components that sit inside those systems, delivering 20% revenue growth and 32% profit margins with a 20% return on equity.
We pass because the shares already price in perfection at 42 times forward earnings for a narrow moat business. Even with a modest cushion to fair value the multiple leaves scant room for the ordinary bumps that hit component suppliers.
Tech cycles turn fast and customers can switch suppliers when cheaper alternatives appear. A narrow edge plus high valuation creates classic downside if growth slows or margins compress. Ethical screen clears but the price tag does not. Analysis, not advice.
Another profit measure, before interest, tax and non-cash costs: EBITDA.
The risks · The things to watch: it already moves more than the market on an average day.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to Trade
VICR trades on NASDAQ. As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
The Dated Journal · Newest First, Never Edited
Every Entry, As Written
2026-11-03Distribution$191.09-1.9%Entry 16
The analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 1.9% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it C. Technically it is holding around 12% above its long-term trend line with momentum reading oversold. Over the past year the shares are up 502%. Our forward projection puts the odds of a 10% gain over the next month near 50%. The street (4 analysts) rates it strong buy, with a mean price target of $346. Insiders have been net sellers over the past quarter.
The framework has shifted from markup to distribution since the last review. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 20.6% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it D. Technically it is holding around 12% above its long-term trend line with momentum reading oversold. Over the past year the shares are up 502%. Our forward projection puts the odds of a 10% gain over the next month near 50%. The street (4 analysts) rates it strong buy, with a mean price target of $346. Insiders have been net sellers over the past quarter.
2026-10-20Markup$245.35+0.0%Entry 14
The analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it A. Technically it is holding around 25% above its long-term trend line with momentum reading bearish. Over the past year the shares are up 502%. Our forward projection puts the odds of a 10% gain over the next month near 50%. The street (4 analysts) rates it strong buy, with a mean price target of $346. Insiders have been net sellers over the past quarter. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-19Markup$245.35+0.0%Entry 13
The analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it A. Technically it is holding around 25% above its long-term trend line with momentum reading bearish. Over the past year the shares are up 502%. Our forward projection puts the odds of a 10% gain over the next month near 50%. The street (4 analysts) rates it strong buy, with a mean price target of $346. Insiders have been net sellers over the past quarter. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-18Markup$245.35+0.0%Entry 12
The analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B. Technically it is holding around 114% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 502%. Our forward projection puts the odds of a 10% gain over the next month near 50%. The street (4 analysts) rates it strong buy, with a mean price target of $346. Insiders have been net sellers over the past quarter. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-17Markup$245.35+0.0%Entry 11
The analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B. Technically it is holding around 114% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 502%. Our forward projection puts the odds of a 10% gain over the next month near 50%. The street (4 analysts) rates it strong buy, with a mean price target of $346. Insiders have been net sellers over the past quarter. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-16Markup$245.35-5.4%Entry 10
The analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 5.4% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B. Technically it is holding around 114% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 502%. Our forward projection puts the odds of a 10% gain over the next month near 50%. The street (4 analysts) rates it strong buy, with a mean price target of $346. Insiders have been net sellers over the past quarter. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-15Markup$259.40+0.0%Entry 9
The analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B. Technically it is holding around 114% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 502%. Our forward projection puts the odds of a 10% gain over the next month near 50%. The street (4 analysts) rates it strong buy, with a mean price target of $346. Insiders have been net sellers over the past quarter. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-14Markup$259.40+0.0%Entry 8
The analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B. Technically it is holding around 114% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 502%. Our forward projection puts the odds of a 10% gain over the next month near 50%. The street (4 analysts) rates it strong buy, with a mean price target of $346. Insiders have been net sellers over the past quarter. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-13Markup$259.40-3.3%Entry 7
The analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 3.3% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B. Technically it is holding around 114% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 502%. Our forward projection puts the odds of a 10% gain over the next month near 50%. The street (4 analysts) rates it strong buy, with a mean price target of $346. Insiders have been net sellers over the past quarter. It reported earnings in this window, a natural checkpoint for the thesis.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
